Structural Biology and Biochemistry of Coronavirus

NIH Pandemic-Era Grants

Pandemic Era Grants

2021

Document text

Principal Investigator: Audray  Harris
Organization: NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Fiscal Year: 2021
Award: $249,426
Funding agency: National Institute of Allergy and Infectious Diseases

Coronaviruses remain both a seasonal health burden and pandemic threat due to the antigenic variation of viral glycoproteins and the ability of animal coronaviruses to cause zoonotic infections in humans. Although conserved epitopes have been identified, there is a fundamental gap in understanding and correlating the disposition of conserved coronavirus epitopes on subunit vaccines and designed nanoparticles with immunogenicity. Lack of such information represents important problems and until they are addressed optimal display of conserved coronavirus epitopes cannot be understood in molecular details. In FY 2021, we  established milestones in the application of structure-guided antigen design for the development of antigens carrying antigenically conserved epitopes from coronaviruses. This will aid in both understanding conserved coronavirus epitope display and the immunogenicity of epitopes on vaccine platforms. This is significant and relevant to public health because it is expected to expand understanding of the structure and epitope disposition of coronavirus epitopes and will aid immunogen evaluation and design for more efficacious coronavirus vaccines.

Terms: <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><3-D><3-Dimensional><3D><Address><Affect><Animals><Antibodies><Antigen Variation><Antigenic Determinants><Antigenic Variability><Antigenic Variation><Antigens><Architecture><B blood cells><B cell><B cells><B-Cells><B-Lymphocytes><B-cell><Binding><Binding Determinants><Biochemical><Bite><COVID crisis><COVID epidemic><COVID pandemic><COVID-19 crisis><COVID-19 epidemic><COVID-19 global health crisis><COVID-19 global pandemic><COVID-19 health crisis><COVID-19 pandemic><COVID-19 public health crisis><COVID-19 virus><COVID19 crisis><COVID19 epidemic><COVID19 global health crisis><COVID19 global pandemic><COVID19 health crisis><COVID19 pandemic><COVID19 public health crisis><COVID19 virus><CoV S protein><CoV glycoprotein S><CoV spike glycoprotein><CoV spike protein><CoV-2><CoV2><Coin><Communicable Diseases><Competence><Complex><Coronaviridae><Coronavirus><Coronavirus glycoprotein S><Coronavirus spike protein><Development><Disease><Disorder><Electron Microscopy><Encapsulated><Engineering / Architecture><Envelope Protein><Epitopes><Evaluation><Formulation><Genome><Geometry><Glycoproteins><Goals><Health><Human><Immune response><Immune system><Immunochemical Immunologic><Immunologic><Immunological><Immunological response><Immunologically><Immunologics><Infectious Disease Pathway><Infectious Diseases><Infectious Disorder><MERS><MERS coronavirus disease><MERS-CoV disease><Membrane><Membrane Protein Gene><Membrane Proteins><Membrane-Associated Proteins><Middle East Respiratory Syndrome><Middle East Respiratory Syndrome CoV disease><Middle East Respiratory Syndrome coronavirus disease><Middle Eastern Respiratory Syndrome><Middle Eastern Respiratory Syndrome CoV disease><Middle Eastern Respiratory Syndrome coronavirus disease><Mission><Modern Man><Molecular><Molecular Interaction><Molecular Modeling Nucleic Acid Biochemistry><Molecular Modeling Protein/Amino Acid Biochemistry><Molecular Models><NIH><Nano platform><Nano-technological platform><Nano-technology platform><Nanoplatform><Nanotechnological platform><National Institutes of Health><Nucleocapsid Proteins><Phase><Proteins><Public Health><Recombinants><Research><SARS Virus><SARS corona virus><SARS corona virus 2><SARS coronavirus><SARS-Associated Coronavirus><SARS-CoV><SARS-CoV-2><SARS-CoV-2 epidemic><SARS-CoV-2 global health crisis><SARS-CoV-2 global pandemic><SARS-CoV-2 pandemic><SARS-CoV2><SARS-CoV2 epidemic><SARS-CoV2 pandemic><SARS-Related Coronavirus><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-coronavirus-2 epidemic><SARS-coronavirus-2 pandemic><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Scaffolding Protein><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome CoV 2 epidemic><Severe Acute Respiratory Syndrome CoV 2 pandemic><Severe Acute Respiratory Syndrome Virus><Severe Acute Respiratory Syndrome corona virus><Severe Acute Respiratory Syndrome coronavirus><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome coronavirus 2 epidemic><Severe acute respiratory syndrome coronavirus 2 pandemic><Severe acute respiratory syndrome related corona virus 2><Structural Biochemistry><Structure><Subunit Vaccines><Surface Proteins><T-Cell Epitopes><T-Cells><T-Lymphocyte><T-Lymphocyte Epitopes><Testing><United States National Institutes of Health><Vaccine Design><Vaccine Production><Vaccines><Viral><Viral Structural Proteins><Viral Vaccines><Virion><Virus><Virus Particle><Wuhan coronavirus><Zoonoses><Zoonotic><Zoonotic Infection><adaptive immune response><allergic/immunologic body system><allergic/immunologic organ system><arm><base><corona virus><corona virus disease 2019 epidemic><corona virus disease 2019 pandemic><coronavirus S protein><coronavirus disease 2019 crisis><coronavirus disease 2019 epidemic><coronavirus disease 2019 global health crisis><coronavirus disease 2019 global pandemic><coronavirus disease 2019 health crisis><coronavirus disease 2019 pandemic><coronavirus disease 2019 public health crisis><coronavirus disease 2019 virus><coronavirus disease crisis><coronavirus disease epidemic><coronavirus disease pandemic><coronavirus spike glycoprotein><coronavirus vaccine><design><designing><develop a vaccine><development of a vaccine><developmental><env Antigens><env Gene Products><env Polyproteins><env Protein><hCoV19><host response><immune system response><immunogen><immunogenicity><immunoresponse><innovate><innovation><innovative><membrane structure><molecular modeling><nCoV2><nano particle><nano-sized particle><nanoparticle><nanosized particle><nanotechnology platform><neutralizing antibody><pan CoV vaccine><pan coronavirus vaccine><pandemic><pandemic disease><particle><produce vaccines><scaffold><scaffolding><severe acute respiratory syndrome coronavirus 2 global health crisis><severe acute respiratory syndrome coronavirus 2 global pandemic><severe acute respiratory syndrome-CoV><structural biology><structural glycoprotein><structural-GP><three dimensional><thymus derived lymphocyte><universal CoV vaccine><universal coronavirus vaccine><vaccine against coronavirus><vaccine antibodies><vaccine development><vaccine efficacy><vaccine formulation><vaccine induced antibodies><vaccine-induced antibodies><viral RNA><virus RNA><virus envelope>